February 24, 2009, Updated September 24, 2012

Medtronic acquires Israel?s Ventor as part of $1.03b heart valve shopping spreeIsrael’s Ventor Technologies, a developer of transcatheter heart valve technologies for the treatment of aortic valve disease, will be acquired by Medtronic for $325 million. The acquisition is one of two Medtronic is executing; it will also purchase CoreValve for $700 million or $1.03 billion in total. The Ventor acquisition adds two more technologies to Medtronic’s transcatheter valve portfolio: a minimally invasive, surgical transapical technology and a next generation percutaneous transfemoral technology. ISRAEL21c last week reported on the impending deal.

Fighting for Israel's truth

We cover what makes life in Israel so special — it's people. A non-profit organization, ISRAEL21c's team of journalists are committed to telling stories that humanize Israelis and show their positive impact on our world. You can bring these stories to life by making a donation of $6/month. 

Jason Harris

Jason Harris

Executive Director

Read more: